Home › NCT06314009
Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
Who can join
Ages 18 to 60 · Women
Full eligibility criteria
Inclusion Criteria: * Singleton pregnancy, less than 24 weeks gestation * Pre-pregnancy BMI between 18.5 - 24.9kg/m2 or ≥30kg/m2 Exclusion Criteria: * Asthma on controller medication * Autoimmune Conditions * Chronic Hypertension * Claustrophobia * Congenital Anomaly * Pregestational Diabetes * History of Bariatric Surgery * HIV * Ineligible for MRI (incompatible implanted medical device) * Multifetal Gestation * Smoking during pregnancy
About the study
The purpose of this study is to evaluate the flow of oxygen and blood necessary for nutrient transfer across the placenta during the second and third trimesters in pregnancy in women who are obese before pregnancy compared to women who have an average weight before pregnancy.
This study will evaluate blood flow across the placenta by functional Magnetic Resonance Imaging (fMRI). The investigators hypothesize that there will be differences in placental oxygenation and blood flow among women with obesity as compared to those with normal weight.
Participants will be asked to complete:
* MRI in the second trimester (20-24 weeks) * MRI in the third trimester (30-34 weeks)
What is being tested
- functional Magnetic Resonance Imaging (fMRI) (diagnostic test)
Sponsor: Endeavor Health · Participants: 30 · Started: May 9, 2024
Contact the study team
- Alexandra Mangus · Phone: (847) 570-2243
- Caitlin A MacGregor, MD · Phone: (847) 570-4729
Official record on ClinicalTrials.gov — NCT06314009
Locations in the U.S.
| Illinois | Endeavor Health, Evanston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.